Focus on Extrapyramidal Dysfunction

Front Matter....Pages I-VIII
Dopaminergic neurotoxicity of homocysteine and its derivatives in primary mesencephalic cultures....Pages 1-13
MTHFR C677T polymorphism, folic acid and hyperhomocysteinemia in levodopa treated patients with Parkinson’s disease....Pages 15-20
Screening for mutations in synaptotagmin XI in Parkinson’s disease....Pages 21-28
Depletion and restoration of endogenous monoamines affects β-CIT binding to serotonin but not dopamine transporters in non-human primates....Pages 29-38
Differential executive control impairments in early Parkinson’s disease....Pages 39-51
Simple movement sequences better correlate to levodopa plasma levels than complex ones....Pages 53-60
Clinical effects of repetitive transcranial magnetic stimulation versus acute levodopa challenge in Parkinson’s disease....Pages 61-67
Impact of apomorphine on BOLD signal during movement in normals....Pages 69-78
Worsened motor test performance following acute apomorphine injection in previously untreated patients with Parkinson’s disease....Pages 79-87
Transdermal lisuride delivery in the treatment of Parkinson’s disease....Pages 89-95
Congruent deterioration of complex and simple movements in patients with Huntington’s disease....Pages 97-104
Methyltetrahydrofolate reductase polymorphism influences onset of Huntington’s disease....Pages 105-110
Coenzyme Q 10 serum levels in Huntington’s disease....Pages 111-116
The N-methyl-D-aspartate antagonist memantine retards progression of Huntington’s disease....Pages 117-122
Transcranial sonography in spinocerebellar ataxia type 3....Pages 123-133
Therapeutic strategies in Friedreich’s ataxia....Pages 135-145
Cholecystokinin- and cholecystokinin-B-receptor gene polymorphisms in panic disorder....Pages 147-156